|
DSTN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.02760030987292E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
2.136200E-02 |
| Stage1-vs-Stage3 |
4.608200E-01 |
| Stage1-vs-Stage4 |
1.136120E-03 |
| Stage2-vs-Stage3 |
1.778380E-02 |
| Stage2-vs-Stage4 |
2.601400E-04 |
| Stage3-vs-Stage4 |
3.515800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.29179999924989E-08 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
8.136100E-02 |
| Caucasian-vs-Asian |
7.390000E-01 |
| AfricanAmerican-vs-Asian |
1.275580E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
9.708600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.5104900000007E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.046200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.448000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.411000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.295600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.298600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.008400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.058500E-03 |
| Classical-VS-Follicular |
7.4641000002984E-07 |
| Classical-VS-Other |
8.895400E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.75269998514693E-09 |
| Tall-VS-Other |
4.219200E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
9.288500E-02 |
| Follicular-VS-Normal |
3.23869819851552E-11 |
| Other-VS-Normal |
1.6332999999924E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
3.8277000000031E-05 |
|
|
